/주식/LXRX
LXRX

LXRX

USD

Lexicon Pharmaceuticals Inc. Common Stock

$1.340+0.010 (0.752%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.330

고가

$1.390

저가

$1.325

거래량

2.72M

기업 기본 정보

시가총액

487.0M

산업

생명공학

국가

United States

거래 통계

평균 거래량

2.36M

거래소

NCM

통화

USD

52주 범위

저가 $0.28현재가 $1.340고가 $1.66

관련 뉴스

GlobeNewswire

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two

더 보기
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans
GlobeNewswire

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior

더 보기
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025